Blog

Microbiome startup raises $90M as it prepares for a potential FDA first

finch-ceo-mark-smith-phd900xx8256-5504-0-0

Finch Therapeutics has raised new capital as it prepares for a potential product launch and large-scale manufacturing.

Read More